Cargando…

Early life stress-induced neuroinflammation and neurological disorders: a novel perspective for research

Detalles Bibliográficos
Autores principales:	Catale, Clarissa, Carola, Valeria, Viscomi, Maria Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848617/ https://www.ncbi.nlm.nih.gov/pubmed/35142680 http://dx.doi.org/10.4103/1673-5374.335152

Ejemplares similares

Exposure to different early-life stress experiences results in differentially altered DNA methylation in the brain and immune system
por: Catale, Clarissa, et al.
Publicado: (2020)

Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline
por: Catale, Clarissa, et al.
Publicado: (2022)

Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development
por: Catale, Clarissa, et al.
Publicado: (2020)

The plasticity of plasticity: lesson from remote microglia induced by focal central nervous system injury
por: Viscomi, Maria Teresa
Publicado: (2019)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

On the value of preprints: An early career researcher perspective
por: Sarabipour, Sarvenaz, et al.
Publicado: (2019)

Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option
por: Ng, Chiao W., et al.
Publicado: (2022)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

The intricate debate on neurodegeneration and neuroinflammation in Parkinson’s disease: which came first?
por: Cardinale, Antonella, et al.
Publicado: (2022)

Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective
por: Ponzano, Stefano, et al.
Publicado: (2017)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

A perspective on causality assessment in epigenetic research on neurodegenerative disorders
por: Koulousakis, Philippos, et al.
Publicado: (2022)

Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders
por: Gorji, Ali
Publicado: (2022)

Non-Communicable Neurological Disorders and Neuroinflammation
por: Ballerini, Clara, et al.
Publicado: (2022)

Editorial: Neuroimaging of neuroinflammation in neurological disorders
por: Uddin, Md Nasir, et al.
Publicado: (2023)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

Neuroinflammation and COVID-19
por: Vanderheiden, Abigail, et al.
Publicado: (2022)

Early Years Research Elective: Changing Perspectives and Dealing with Uncertainty
por: Dawidziuk, Aleksander, et al.
Publicado: (2020)

Vascular cognitive impairment and dementia: An early career researcher perspective
por: Silva, Nárlon C. Boa Sorte, et al.
Publicado: (2022)

Functional neurological disorders: an Australian interdisciplinary perspective
por: Pepper, Elizabeth, et al.
Publicado: (2022)

Novel insights in phosphodiesterase 4 subtype inhibition to target neuroinflammation and stimulate remyelination
por: Schepers, Melissa, et al.
Publicado: (2023)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

Chemical Systems for Wetware Artificial Life: Selected Perspectives in Synthetic Cell Research
por: Stano, Pasquale
Publicado: (2023)

The multifaceted potential of the lipid transmitter oleoylethanolamide to treat alcohol-induced neuroinflammation and alcohol use disorders
por: Orio, Laura
Publicado: (2019)

N-acetyl proline-glycine-proline: implications for neurological disorders
por: Hill, Jeff W., et al.
Publicado: (2016)

Progress in mimicking brain microenvironments to understand and treat neurological disorders
por: Ngo, Mai T., et al.
Publicado: (2021)

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022)

H(2)S and Oxytocin Systems in Early Life Stress and Cardiovascular Disease
por: McCook, Oscar, et al.
Publicado: (2021)

Consequences of early life stress on the structure and function of the adult mouse retina
por: Calanni, Juan S., et al.
Publicado: (2023)

Neurological manifestations of COVID-19: A perspective from Pakistani medical students
por: Adil, Mariam, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress in Osteoarthritis: A Novel Perspective on the Pathogenesis and Treatment
por: Wen, Zeqin, et al.
Publicado: (2023)

Perspectives of physiome research
por: Leem, Chae Hun
Publicado: (2016)

Studying neurological disorders using induced pluripotent stem cells and optogenetics
por: Chin, Eunice W.M., et al.
Publicado: (2015)

Disease-directed engineering for physiology-driven treatment interventions in neurological disorders
por: Wood, Thomas, et al.
Publicado: (2019)

Augmentation of transforming growth factor-β signaling for the treatment of neurological disorders
por: Luo, Jian
Publicado: (2023)

Neurodegeneration and neuroinflammation: two processes, one target
por: Carriba, Paulina, et al.
Publicado: (2015)

Microglial exosomes in retinal neuroinflammation: focus in glaucoma
por: Aires, Inês Dinis, et al.
Publicado: (2021)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Advanced brain organoids for neuroinflammation disease modeling
por: Sabate-Soler, Sonia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_din90gotof0hbqils13u401uja